10th

EPH Conference logo

 

Sustaining resilient and
healthy communities

Stockholm, Sweden
1 - 4 November 2017

Lunch Symposiums

 

We are excited to announce an interesting programme of lunch symposiums on Friday 11 November. Delegates who are registered for the main EPH Conference can attend these meetings and lunch symposiums free of charge.

 

RESEARCH, PRACTICE AND POLICY: ALL FOR HEALTH 

Friday 11 November, 12:50 – 13:50, Hall E

Organised by
ECDC and EUPHA 

This lunch seminar, organized as a round table will focus on the challenges and opportunities of transferring knowledge form research to practice and policy. Classically three different areas in society they should ideally “talk to each other” in order to ensure evidence-based practices and policies.

How this ideal can be turned into practice remains a challenge – who should do it? How? How should Europe move ahead in this area? These are some questions that the panel will aim to answer. It will bring together researchers, decision makers, policy makers and practitioners that will contribute with their view in an attempt to find the “common ground” of knowledge sharing. Each of the round table participants will present a concrete experience from their field of work (see below) currently. The discussion should focus on what is the current situation, strengths and gaps so what should be improved in the future.

The interventions will be short (3-5 min), as “teasers” to start a discussion among round table members and with the audience.

Chaired and moderated by
Karl Ekdahl (ECDC) and Günter Pfaff (EUPHA)

Speakers
Andrea Ammon, Acting Director ECDC: focus on an example from communicable disease area in bringing research-policy-practice together;

Gauden Galea, Director, Division of Non-Communicable Diseases and Promoting Health through the Life-Course, WHO Regional Office for Europe: focus on an example from non-communicable disease area in bringing research-policy-practice together

Isabel de La Mata, European Commission: focus on policy at EU level and the link with research and practice

Ricardo Baptista Leite, Member of Parliament, Portugal, Head of Public Health, Catholic University of Portugal: focus on policy at national level

Aura Timen, President of the EUPHA Section on Infectious diseases: EUPHA-IDC contribution to the network of researchers, policy makers and practitioners in infectious diseases

Gindrovel Dumitra, General Practitioner from Romania: focus on how policy and research influence his practice

Erik Baekkeskov, University of Melbourne, Australia: the perspective of a policy science researcher on how research-policy-practice should work together – what can we learn from the 2009 pandemic?

 

HEALTH FOR ALL: ACCELERATING PREVENTION IN HEALTH CARE SYSTEMS, THE ROLE OF ADULT VACCINATION

Friday 11 November, 12:50 – 13:50, Room L7

Organised by
EUPHA, Pfizer

Welcome and scene setting – The current environment 
Jane Barratt, International Federation on Ageing, Canada

Societal and social value of adult pneumococcal vaccination 
David Bloom, Harvard School of Public Health, United States

The International Federation on Ageing perspective on adult immunisation and healthy ageing 
Jane Barratt, International Federation on Ageing, Canada 

The Greek perspective on vaccination – What can we learn from this preventative approach? 
Kostas Athanasakis, National School of Public Health, Greece

Meeting summary, Q&A and close
Jane Barratt, International Federation on Ageing, Canada

Detailed programme is available here

Background
Can vaccination provide a valuable preventative public health measure to address the challenges of Europe’s ageing demographic? Global health experts present their perspectives.

Pneumococcal disease (PD) is responsible for considerable morbidity and mortality across Europe and causes approximately 1.6 million deaths per year worldwide, of which almost half of this number are adults. In Europe, the cost of all-cause pneumonia alone is approximately €10.1 billion annually. However, contrary to infant vaccination, adults are far less concerned, or even aware, of vaccination as an effective prevention strategy against pneumococcal pneumonia.

Findings from PneuVUE®, a new study conducted by Ipsos MORI, in partnership with Pfizer, show that across Europe there is a generally poor understanding about the risks and prevention of pneumonia and the existence of vaccines that protect against some bacterial strains of pneumococcal pneumonia. Eight out of ten adults at risk report they are not vaccinated and the same number (78%) do not feel personally concerned about the risk of catching pneumonia.

The symposium will review the role of vaccination as a sustainable public health approach to addressing specific health challenges posed by Europe’s ageing population. Focusing on the impact of pneumococcal disease, and learning from the experience of Greece and non-European countries, including the United States and Canada, experts will discuss how increased public awareness and government support around adult vaccination can deliver social and societal value and support the healthy ageing of individuals. The session will further present some of the findings of the PneuVUE® study, which is also backed by the speakers.

This session is organised by EUPHA and Pfizer Vaccines and funded by Pfizer Vaccines. 

 

TOWARDS REDUCTION OF INEQUALITIES IN EUROPE: CONTRIBUTION OF EEA GRANTS / NORWAY GRANTS MECHANISM

Friday 11 November, 12:50 – 13:50, Room L2 

Organised by
Norwegian Institute of Public Health

The EEA Grants and Norway Grants represent the contribution of Iceland, Liechtenstein and Norway to reducing economic and social disparities and to strengthening bilateral relations with 16 EU countries in Central and Southern Europe and the Baltics. This lunch symposium, organised by the Norwegian Institute of Public Health in cooperation with the Norwegian Directorate of Health presents results from the ‘Public Health Initiatives’ to reduce health inequalities in Europe.

The lunch symposium also aims to increase awareness of this opportunity during the new period of the Grants, which will last until 2021.

Detailed programme is available here.

More information about the EEA Grants and Norway Grants 'Public Health Initiatives’ programme is available here.

 

Andrija Štampar Award Ceremony for Richard Horton, Editor-in-Chief of The Lancet

Friday 11 November, 12:50 – 13:50, Room L4

Each year, ASPHER awards the Andrija Štampar Medal to a distinguished person for excellence in the field of Public Health. The Medal is named after Dr. Andrija Štampar who was one of the founders of the World Health Organization and chaired its first General Assembly in 1948. Andrija Štampar also founded the School of Public Health in Zagreb, Croatia. This year - the 50-year anniversary of ASPHER -, the Andrija Štampar is awarded to Dr Richard Horton, Editor-in-Chief of the prestigious journal The Lancet. Richard Horton has worked as a passionate advocate for improving the health of the population, in addition to promoting high-quality research in medicine and public health.

Laudatio by Martin McKee, London School of Hygiene and Tropical Medicine, United Kingdom